Healthcare

Orthocell Ltd's (ASX:OCC) Global Expansion Strategy Gains Momentum with Strong Sales Growth for Remplir™
January 22, 2025 12:36 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,Ltd (,ASX:OCC,) expands,Remplir,™ into global markets, backed by strong sales growth.,The US market opportunity,valued,at ~US,$1.6 billion,per year.,Anticipated FDA clearance for,Remplir,™ set for March/April 2025.,Orthocell Ltd...

Compumedics Secures 5-Year Philips Contract for Somfit Sleep Device, Expands U.S. Market Presence
January 22, 2025 12:10 PM AEDT| By Team Kalkine MediaHighlights,New 5-Year Agreement with Philips:,Compumedics will continue supplying its,Somfit device,to Philips' pharmacy-based sleep program in Australia through 2028, solidifying its position in the rapidly growing pharmacy-based sleep testing marke...

Can Orthocell Revolutionize Regenerative Medicine Globally?
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Accelerating international market entry for Remplir in the regenerative medicine sector.,Expanding presence in regions including Australia, New Zealand, Singapore, and the United States.,Robust financial resources and ongoing regulatory su...

AdAlta is focusing on an 'East to West' approach for cellular immunotherapy to enhance value creation.
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaAdAlta's Strategic Move: East to West Cellular Immunotherapy Growth

Is EZZ Life Science Expanding Its Global Reach?
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Partnership with the Australian Open enhances exposure across Asia,Revenue growth driven largely by the Chinese market,Entry into the US market backed by US Food & Drug Administration approved products,EZZ Life Science (ASX:EZZ) has enter...

Can ISLA-101 Change the Fight Against Dengue Fever?
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:,Island Pharmaceuticals completes enrolment for the phase 2b segment of the PROTECT trial.,The trial examines ISLA-101’s role in reducing dengue virus symptoms.,Comprehensive trial data expected in the final quarter of FY25,Island Pharmace...
Cardiex (ASX:CDX) Pioneers Health Monitoring with CONNEQT Pulse Launch
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaCardiex (ASX:CDX) Pioneers Health Monitoring with CONNEQT Pulse Launch

What’s Driving Pacific Edge, LTR Pharma, and Orthocell’s Latest ASX Developments?
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights:.,Pacific Edge (ASX:PEB),challenges a US decision impacting Medicare reimbursement for its bladder cancer diagnostic test, Cxbladder.,LTR Pharma (ASX:LTP),secures a key distribution partnership with Symbion to advance its erectile dysfunct...

Ready to Revolutionize Pediatric Neurological Treatments?
January 22, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,● Neurotech International (ASX:NTI) partners with RH Farma Dooel Skopje under a binding development agreement.,● The collaboration focuses on a pharmaceutical-grade broad-spectrum cannabinoid drug for pediatric neurological disorders.,● Th...

Is the Recent Performance of Sonic Healthcare Limited (ASX:SHL) Stock Influenced by Its Financial Health?
January 21, 2025 11:32 PM AEDT| By Team Kalkine MediaIs the Recent Performance of Sonic Healthcare Limited (ASX:SHL) Stock Influenced by Its Financial Health?

SDI Limited Financial Strength Amid Market Fluctuations
January 21, 2025 05:31 PM AEDT| By Team Kalkine MediaSDI Limited Financial Strength Amid Market Fluctuations

Respiri Acquires Orb Health Inc. to Strengthen U.S. Market Position
January 21, 2025 12:04 PM AEDT| By Team Kalkine MediaHighlights,Acquisition of Orb Health:,Respiri has successfully acquired,Orb Health Inc.,for,US$9 million,in shares, marking a significant milestone in its expansion into the,U.S. connected and chronic care health market,.,Additional investment from O...

Lumos Diagnostics (ASX:LDX) Shares Up 31%, Business Prospects Need Improvement
January 21, 2025 11:36 AM AEDT| By Team Kalkine MediaLumos Diagnostics (ASX:LDX) Shares Up 31%, Business Prospects Need Improvement

Insiders Forfeit AU$265k with Emyria Stock Declining to AU$0.03
January 21, 2025 11:35 AM AEDT| By Team Kalkine MediaInsiders Forfeit AU$265k with Emyria Stock Declining to AU$0.03
A year ago, purchasing shares in Ansell (ASX:ANN) would have yielded a 49% return.
January 21, 2025 11:30 AM AEDT| By Team Kalkine MediaHighlights:,Ansell Limited (ASX:ANN) shares outperformed the market significantly over the past year.,Total shareholder return outpaces simple share price gains when dividends are included.,Insider buying and analyst forecasts may indicate further po...

ASX Biotech Companies Focused on Early Cancer Detection
January 21, 2025 11:00 AM AEDT| By Team Kalkine MediaPioneering Advances in Cancer Detection by ASX-Listed Biotechs

Orthocell Ltd. (ASX:OCC) Secures A$3.18 Million R&D Refund and Strengthens Global Market Position
January 20, 2025 01:43 PM AEDT| By Team Kalkine MediaHighlights,Orthocell,Ltd. (,ASX:OCC,) receives,a A,$3.18 million R&D tax refund, boosting its cash reserves to A$33 million.,The company is preparing for a US market entry with its innovative medical devices.,A strategic global expansion is underway,...

EBR's prospects for its US heart lead improve as the wireless device receives approval for expedited reimbursement.
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaEBR's prospects for its US heart lead improve as the wireless device receives approval for expedited reimbursement.

Optiscan (ASX:OIL) Initiates GI Study in Germany Using Its Initial Imaging Prototype
January 19, 2025 11:00 AM AEDT| By Team Kalkine MediaOptiscan Advances GI Imaging Technology with New Pre-Clinical Study

Is Little Green Pharma (ASX:LGP) Making Prudent Use of Debt?
January 18, 2025 01:32 PM AEDT| By Team Kalkine MediaIs Little Green Pharma (ASX:LGP) Making Prudent Use of Debt?

Advertise your brand on Kalkine Media